GANX
Gain Therapeutics Inc
1.80$
+0.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | |
| – | +247.0% | +273.1% | +61.4% | +314.4% | +30.3% | +0.6% | +11.9% | |
| – | – | – | +928.1% | +81.9% | +113.5% | -26.7% | -24.6% | |
| – | – | – | – | -28.3% | – | – | – | |
| – | -2.2% | -23.9% | -238.9% | – | -70.8% | -344.3% | – | |
| – | +71.8% | +51.8% | +352.4% | +26.3% | -87.1% | +46.5% | -100.0% | |
| – | +71.8% | +51.8% | +352.4% | +15,582.5% | – | -51.3% | – | |
| – | -25.0% | +0.0% | -103.0% | +258.9% | +13.1% | +2.0% | +6.2% | |
| – | +78.0% | +498.7% | +298.3% | -100.2% | – | +2.9% | +118.6% | |
| – | -140.9% | – | +309.0% | -200.6% | – | -131.5% | – | |
| – | – | – | – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.